CD4 and neoplasm: In one study that generated tumour-specific CD8+ cytotoxic T cells from allogeneic donors, MLTCs were initiated with a highly purified population of CD8+ donor lymphocytes potentially underestimating the role of CD4+ clones in the immune response.